1-11 of 11
Maria L. Delioukina
Close
Sort by
Journal Articles

Subcutaneous Daratumumab Plus Standard Treatment Regimens in Patients with Multiple Myeloma across Lines of Therapy: Pleiades Study Update

Ajai Chari, MD, Jesús San-Miguel, Helen McCarthy, MBBS, PhD, Kenshi Suzuki, MD PhD, Vania T.M. Hungria, MD PhD, Anna Sureda, MD PhD, Aurore Perrot, MD PhD, Cyrille Hulin, MD, Hila Magen, MD, Shinsuke Iida, MD PhD, Vladimir Maisnar, MD PhD MBA, Lionel Karlin, MD, Ludek Pour, MD, Dolly A. Parasrampuria, PhD, Tara Masterson, Michele Kosh, RN, BSN, Shiyi Yang, Maria L. Delioukina, MD, Ming Qi, MD PhD, Robin Carson, MD BA, Cyrille Touzeau, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3152.
https://doi.org/10.1182/blood-2019-123560
Published: 2019
Journal Articles

Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma

Clinical Trials & Observations
Steven M. Horwitz, Youn H. Kim, Francine Foss, Jasmine M. Zain, Patricia L. Myskowski, Mary Jo Lechowicz, David C. Fisher, Andrei R. Shustov, Nancy L. Bartlett, Maria L. Delioukina, Tony Koutsoukos, Michael E. Saunders, Owen A. O'Connor, Madeleine Duvic
Journal: Blood
Blood (2012) 119 (18): 4115–4122.
https://doi.org/10.1182/blood-2011-11-390211
Published: 2012
Journal Articles

Brentuximab Vedotin (SGN-35) Enables Successful Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma

Robert W. Chen, MD, Stephen J. Forman, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS, Leslie Popplewell, MD, Maria L Delioukina, MD, Torres Alejandra, MS, Bernadette Pulone, RN, OCN, Eileen P. Smith, MD, Auayporn P. Nademanee, MD, Chatchada Karanes, MD, Paul O'Donnell, MD, PhD, David G. Maloney, MD, PhD, Len Farol, MD, Schickwann Tsai, MD, PhD, Laurie E. Grove, PA-C, Ajay K. Gopal, MD
Journal: Blood
Blood (2011) 118 (21): 664.
https://doi.org/10.1182/blood.V118.21.664.664
Published: 2011
Journal Articles

A Pilot Phase II Study of the Lyn Kinase Inhibitor Bafetinib in Patients with Relapsed or Refractory B Cell Chronic Lymphocytic Leukemia

Tapan Kadia, Maria L Delioukina, MD, Hagop M. Kantarjian, Michael J Keating, MD, William G. Wierda, MD, PhD, Jan A. Burger, MD, PhD, Scott Wieland, MBA, PhD, Daniel Levitt, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2858.
https://doi.org/10.1182/blood.V118.21.2858.2858
Published: 2011
Journal Articles

Identification of An Active, Well-Tolerated Dose of Pralatrexate In Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma (CTCL): Final Results of a Multicenter Dose-Finding Study.

Steven M Horwitz, Youn H. Kim, MD, Francine M Foss, MD, Jasmine M. Zain, MD, Patricia Myskowski, MD, Mary Jo Lechowicz, MD, David C. Fisher, MD, Andrei Shustov, MD, Nancy L. Bartlett, MD, Maria L Delioukina, MD, Tony Koutsoukos, PhD, Steven M. Fruchtman, MD, Owen A. O'Connor, MD, PhD, Madeleine Duvic, MD
Journal: Blood
Blood (2010) 116 (21): 2800.
https://doi.org/10.1182/blood.V116.21.2800.2800
Published: 2010
Journal Articles

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Plus Rituximab in Newly Diagnosed, Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Mark Kirschbaum, MD, Leslie Popplewell, M.D., Maria L Delioukina, MD, Robert w Chen, Vinod Pullarkat, Paul Frankel, Joel Conrad, Joyce Hartshorn, Auayporn Nademanee, M.D., Stephen Forman, MD
Journal: Blood
Blood (2010) 116 (21): 3957.
https://doi.org/10.1182/blood.V116.21.3957.3957
Published: 2010
Journal Articles

Final Report of a Phase I Study of Clofarabine Plus High Dose Melphalan as a Conditioning Regimen for Allogeneic Transplantation

Mark Kirschbaum, MD, Anthony Selwyn Stein, M.D., Paul Frankel, Leslie Popplewell, M.D., Robert w Chen, Maria L Delioukina, MD, Ryotaro Nakamura, MD, David S. Snyder, MD, Cynthia Slape, Christopher Ruel, Joel Conrad, Auayporn Nademanee, M.D., Stephen Forman, MD
Journal: Blood
Blood (2010) 116 (21): 528.
https://doi.org/10.1182/blood.V116.21.528.528
Published: 2010
Journal Articles

Graft Versus Host Disease Correlates with Increased Survival After Allogeneic Stem Cell Transplant for Mature T-Cell Lymphomas: Evidence of Graft Versus T-Cell Lymphoma Effect.

Maria L Delioukina, MD, Joycelynne Palmer, PHD, Jasmine M. Zain, MD, NC Tsai, Auayporn P. Nademanee, MD, Stephen J Forman, MD
Journal: Blood
Blood (2009) 114 (22): 3367.
https://doi.org/10.1182/blood.V114.22.3367.3367
Published: 2009
Journal Articles

Genomic Alterations in Hodgkin’s and Reed/Sternberg (HRS) Cells at Disease Onset Reveals Distinct Signatures for Chemosensitive and Primary Refractory Hodgkin’s Lymphoma.

Marilyn L. Slovak, Victoria Bedell, Dolores Bobadilla, Norma J Nowak, Maria L. Delioukina, Lawrence M. Weiss, David Smith, Stephen J. Forman
Journal: Blood
Blood (2008) 112 (11): 1451.
https://doi.org/10.1182/blood.V112.11.1451.1451
Published: 2008
Journal Articles

Analysis of Predictive Power of Prednisone Dose at 3 Months of Treatment on CGVHD Prognosis.

Pablo M. Parker, MD, Ryotaro Nakamura, MD, Vinod Pullarket, MD, Joseph Rosenthal, MD, Eileen P. Smith, MD, David S. Snyder, MD, Jasmine M. Zain, MD, George Somlo, MD, Annette Brown, Hanjoo Kim, Joycelynne Palmer, PhD, Ji-Lian Cai, MD, Maria L. Delioukina, MD, Peter M. Falk, MD, Chatchada Karanes, MD, Neil M. Kogut, MD, Amrita Krishnan, MD, Auayporn P. Nademanee, MD, Margaret R. O’Donnell, MD, Leslie Popplewell, MD, Firoozeh Sahebi, MD, Ricardo Spielberger, MD, Anthony S. Stein, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2007) 110 (11): 1975.
https://doi.org/10.1182/blood.V110.11.1975.1975
Published: 2007
Journal Articles

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Relapsed or Refractory Indolent Non Hodgkin Lymphoma. A California Cancer Consortium Study.

Mark H. Kirschbaum, MD, Jasmine M. Zain, MD, Leslie Popplewell, MD, Vinod Pullarkat, MD, Auayporn P. Nademanee, MD, Maria L. Delioukina, MD, Bernadette Pulone, RN, Deron Matsuoka, BS, Paul Frankel, PhD, Zwiebel A. James, MD, Stephen J. Forman, MD, Edward Newman, PhD, David Gandara, MD
Journal: Blood
Blood (2007) 110 (11): 2568.
https://doi.org/10.1182/blood.V110.11.2568.2568
Published: 2007